Federal regulators Monday narrowed the approved uses of the controversial antibiotic Ketek, and said they will add new safety warnings for the drug. The move is the latest in years of maneuvering over ...
The Ketek antibiotic scandal at Sanofi-Aventis (SNY) is receding into ancient history (if you agree that 2007 is "ancient"), so it's not until you read this new class action ruling that you are ...
A former employee for a Sanofi-Aventis contractor overseeing a clinical trial of the antibiotic Ketek told Congress the drugmaker knew of a problem with the study before it was discovered by ...
A senior-level FDA safety official recently called for a halt to a clinical trial of the antibiotic Ketek in children, citing indications of the drug's unusual toxicity. Sanofi-Aventis has been ...
Reports of liver damage after taking Sanofi-Aventis’ antibiotic Ketek have prompted the US Food and Drug Administration to start an investigation into the drug. Reports of liver damage after taking ...
Ketek® (telithromycin), the first in a new class of antibiotics called ketolides, has been granted marketing authorisation by the European Commission for the treatment of community-acquired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results